Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities

View ORCID ProfileIdan Yelin, Rachel Katz, Esma Herzel, Tamar Berman-Zilberstein, Amir Ben-Tov, Jacob Kuint, Sivan Gazit, Tal Patalon, Gabriel Chodick, Roy Kishony
doi: https://doi.org/10.1101/2021.03.16.21253686
Idan Yelin
1Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Idan Yelin
Rachel Katz
2Maccabitech, Maccabi Health Services, Tel Aviv-Yafo, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esma Herzel
2Maccabitech, Maccabi Health Services, Tel Aviv-Yafo, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamar Berman-Zilberstein
3Maccabi Healthcare Services, Tel Aviv-Yafo, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amir Ben-Tov
2Maccabitech, Maccabi Health Services, Tel Aviv-Yafo, Israel
4Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob Kuint
2Maccabitech, Maccabi Health Services, Tel Aviv-Yafo, Israel
4Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sivan Gazit
2Maccabitech, Maccabi Health Services, Tel Aviv-Yafo, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tal Patalon
2Maccabitech, Maccabi Health Services, Tel Aviv-Yafo, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel Chodick
2Maccabitech, Maccabi Health Services, Tel Aviv-Yafo, Israel
4Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roy Kishony
1Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel
5Faculty of Computer Science, Technion - Israel Institute of Technology, Haifa, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rkishony@technion.ac.il
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Vaccinations are considered the major tool to curb the current SARS-CoV-2 pandemic. A randomized placebo-controlled trial of the BNT162b2 vaccine has demonstrated a 95% efficacy in preventing COVID-19 disease. These results are now corroborated with statistical analyses of real-world vaccination rollouts, but resolving vaccine effectiveness across demographic groups is challenging. Here, applying a multivariable logistic regression analysis approach to a large patient-level dataset, including SARS-CoV-2 tests, vaccine inoculations and personalized demographics, we model vaccine effectiveness at daily resolution and its interaction with sex, age and comorbidities. Vaccine effectiveness gradually increased post day 12 of inoculation, then plateaued, around 35 days, reaching 91.2% [CI 88.8%-93.1%] for all infections and 99.3% [CI 95.3%-99.9%] for symptomatic infections. Effectiveness was uniform for men and women yet declined mildly but significantly with age and for patients with specific chronic comorbidities, most notably type 2 diabetes. Quantifying real-world vaccine effectiveness, including both biological and behavioral effects, our analysis provides initial measurement of vaccine effectiveness across demographic groups.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the ISRAEL SCIENCE FOUNDATION (grant No. 3633/19) within the KillCorona-Curbing Coronavirus Research Program.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was approved by the ethics committee of Maccabi Healthcare Services, Tel-Aviv, Israel. The IRB includes an exempt from informed consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Due to patient privacy concerns, data is only available through a remote server, pending MTA.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted March 17, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities
Idan Yelin, Rachel Katz, Esma Herzel, Tamar Berman-Zilberstein, Amir Ben-Tov, Jacob Kuint, Sivan Gazit, Tal Patalon, Gabriel Chodick, Roy Kishony
medRxiv 2021.03.16.21253686; doi: https://doi.org/10.1101/2021.03.16.21253686
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities
Idan Yelin, Rachel Katz, Esma Herzel, Tamar Berman-Zilberstein, Amir Ben-Tov, Jacob Kuint, Sivan Gazit, Tal Patalon, Gabriel Chodick, Roy Kishony
medRxiv 2021.03.16.21253686; doi: https://doi.org/10.1101/2021.03.16.21253686

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (556)
  • Anesthesia (135)
  • Cardiovascular Medicine (1766)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (313)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (661)
  • Epidemiology (10808)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2959)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1932)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (632)
  • Infectious Diseases (except HIV/AIDS) (12523)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2804)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1472)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5380)
  • Radiology and Imaging (1015)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)